MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | APX-Gabapentin | |
New | APX-Pravastatin | |
New | Cabazitaxel Juno | |
New | Enspryng | |
New | Erlotinib Apotex | |
New | Flosix | |
New | Ganirelix Sun | |
New | La Roche-Posay Cicaplast | |
New | La Roche-Posay Toleraine | |
New | Levetiracetam GH Oral Solution | |
New | Lurasidone Sandoz | |
New | Metaraminol MYX | |
New | Mvasi | |
New | Posaconazole ARX | |
New | Potassium Chloride in Sodium Chloride Intravenous Infusion | |
New | Prebalin | |
New | Rusquen | |
New | Shingrix | |
New | Trientine Dr. Reddy's | |
New | Trimbow | |
New | Truxima | |
New | Yondelis | |
Reinstated | Valpro EC | |
Revised | Abilify | Special Warnings and Precautions for Use |
Revised | Acarizax | Adverse Effects (Undesirable Effects) |
Revised | Actacode | Boxed Warnings, Contraindications, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Actonel EC Once-a-Week | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Overdose, Pharmaceutical Form, Pharmacological Properties, Physicochemical Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Actonel, Actonel Once-a-Month | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Overdose, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | Actrapid Preparations | Dose and Method of Administration, Nature and Contents of Container, Special Precautions for Storage |
Revised | Alecensa | Adverse Effects (Undesirable Effects) |
Revised | Amgevita | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Anastrozole-GH | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Pharmacological Properties, Product Name change, Special Warnings and Precautions for Use |
Revised | AndroForte 5 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Ezetimibe | Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | APO-Irbesartan HCTZ | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Lansoprazole | Pharmacological Properties |
Revised | APO-Telmisartan HCTZ | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | APX-Paracetamol/Codeine | Boxed Warnings, Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | APX-Sotalol | TGA Date |
Revised | Arimidex | Adverse Effects (Undesirable Effects) |
Revised | Aropax | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Asacol | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Atgam | Special Precautions for Storage |
Revised | Atorvastatin SZ | TGA Date |
Revised | Avaxim | Adverse Effects (Undesirable Effects) |
Revised | Avsartan | Adverse Effects (Undesirable Effects) |
Revised | Baxter Potassium Chloride (0.15% or 0.224%) and Glucose (5%) Intravenous Infusion | Special Warnings and Precautions for Use |
Revised | Bicalox | Sponsor |
Revised | Biktarvy | Shelf Life |
Revised | Bimprozt | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | Blincyto | Adverse Effects (Undesirable Effects), Incompatibilities, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Bisolvon Chesty Forte Oral Liquid | Deleted Presentation |
Revised | Blooms the Chemist Ezetimibe | Special Warnings and Precautions for Use |
Revised | Blooms the Chemist Irbesartan HCTZ | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Boostrix (preservative free) | Dose and Method of Administration, Fertility, Pregnancy and Lactation, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Boostrix-IPV | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Brenda-35 ED | New contraindication, Special Warnings and Precautions for Use |
Revised | BTC Pregabalin | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Buvidal Monthly | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Buvidal Monthly | Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Name of Medicine, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Buvidal Weekly | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Buvidal Weekly | Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Byetta | Adverse Effects (Undesirable Effects) |
Revised | Cafnea | TGA Date |
Revised | Cimzia | Adverse Effects (Undesirable Effects) |
Revised | Cipla Bleomycin 15K | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Cipla Gefitinib | Adverse Effects (Undesirable Effects) |
Revised | Coregas Medical Oxygen and Oxygen (Liquid) | TGA Date |
Revised | Coveram | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | COVID-19 Vaccine AstraZeneca | Adverse Effects (Undesirable Effects), New contraindication, Special Warnings and Precautions for Use |
Revised | Cubicin | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Cuvitru | Adverse Effects (Undesirable Effects) |
Revised | Cyclosporin Sandoz | Special Precautions for Storage |
Revised | Cyproterone Sandoz | Special Warnings and Precautions for Use |
Revised | Cyproterone Sandoz 50 mg | Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | DBL Pentamidine Isethionate for Injection | Nature and Contents of Container, Sponsor |
Revised | Dipentum | List of Excipients, Physicochemical Properties |
Revised | Dukoral | TGA Date |
Revised | DuoResp Spiromax | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Dupixent | Adverse Effects (Undesirable Effects) |
Revised | Duride | Qualitative and Quantitative Composition |
Revised | Duromine | Qualitative and Quantitative Composition |
Revised | EllaOne | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Entecavir Mylan | Pharmacological Properties |
Revised | Epclusa | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Epilim | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Epilim IV | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Esopreze | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition |
Revised | Evicel | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Fareston | Special Warnings and Precautions for Use |
Revised | Fluconazole Apotex | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Fosamax Plus | Special Warnings and Precautions for Use |
Revised | Gabacor | Adverse Effects (Undesirable Effects), Boxed Warnings, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Gabapentin APOTEX Capsules | Adverse Effects (Undesirable Effects), Boxed Warnings, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Gabapentin Sandoz | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Gazyva | Dose and Method of Administration |
Revised | GenRx Tamoxifen | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | GlucaGen HypoKit | Special Warnings and Precautions for Use |
Revised | Grazax | Adverse Effects (Undesirable Effects) |
Revised | Hexaxim | Shelf Life |
Revised | Hyrimoz | Adverse Effects (Undesirable Effects) |
Revised | Imatinib-Teva | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Imbruvica | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Imukin | List of Excipients |
Revised | Imuran | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Shelf Life |
Revised | Irbesartan GH | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Irbesartan/HCT Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Jene-35 ED | Sponsor |
Revised | Kevtam | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Kivexa | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Kytril | Pharmaceutical Form, Special Precautions for Disposal |
Revised | Lexam | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Lincomycin SXP | Sponsor |
Revised | Lorviqua | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Lunava | TGA Date |
Revised | Lurasidone Sandoz | Adverse Effects (Undesirable Effects), List of Excipients, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Mavenclad | Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Mekinist | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Metermine | Qualitative and Quantitative Composition |
Revised | Metformin Sandoz 1000 mg | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Product Name change, Special Warnings and Precautions for Use |
Revised | Metformin Sandoz 500 mg and 850 mg | Nature and Contents of Container |
Revised | Metronidazole Kabi | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Minims Cyclopentolate Eye Drops | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Mizart HCT | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Monofer | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | MycoCept | Adverse Effects (Undesirable Effects) |
Revised | Mycophenolate Sandoz | TGA Date |
Revised | Natrilix | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Natrilix SR | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Neoral | Special Precautions for Storage |
Revised | Nexium | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition |
Revised | Nexium Hp7 | Adverse Effects (Undesirable Effects) |
Revised | Nexium IV | Adverse Effects (Undesirable Effects) |
Revised | NovoMix | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Name of Medicine, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | NovoRapid | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Name of Medicine, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Nplate | Adverse Effects (Undesirable Effects) |
Revised | Nupentin | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ogivri | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Incompatibilities, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Olmertan Combi | Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Shelf Life, Special Precautions for Storage |
Revised | Olumiant | Adverse Effects (Undesirable Effects), Shelf Life |
Revised | Oncaspar Powder for Injection | Adverse Effects (Undesirable Effects) |
Revised | Ondansetron Accord | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Overdose |
Revised | Ovestin Cream | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Ovestin Ovula | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Oxaliplatin Accord | List of Excipients, Qualitative and Quantitative Composition |
Revised | Pamisol | Sponsor |
Revised | Panafcort | Adverse Effects (Undesirable Effects) |
Revised | Panafcortelone | Adverse Effects (Undesirable Effects) |
Revised | Panthron | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, List of Excipients, Nature and Contents of Container, Special Warnings and Precautions for Use, Sponsor |
Revised | Panto | Adverse Effects (Undesirable Effects) |
Revised | Pharmacor Mycophenolate 250 | Adverse Effects (Undesirable Effects) |
Revised | Pharmacor Mycophenolate 500 | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Physicochemical Properties, Special Precautions for Disposal, Special Warnings and Precautions for Use |
Revised | Phebra Potassium Dihydrogen Phosphate 13.6% | Nature and Contents of Container, Pharmaceutical Form, Physicochemical Properties, Product Name change, Qualitative and Quantitative Composition |
Revised | Predmix | Adverse Effects (Undesirable Effects) |
Revised | Predsol Suppository and Retention Enema | Adverse Effects (Undesirable Effects) |
Revised | Predsolone | Adverse Effects (Undesirable Effects) |
Revised | Predsone | Adverse Effects (Undesirable Effects) |
Revised | Pregabalin APOTEX | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Special Warnings and Precautions for Use |
Revised | Prezcobix | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Prezista | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Progout | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Pryzex (New Formulation) | Qualitative and Quantitative Composition |
Revised | Redipred | Adverse Effects (Undesirable Effects) |
Revised | Regaine | Nature and Contents of Container, Pharmaceutical Form |
Revised | Reminyl | List of Excipients, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Rimycin | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Rinvoq | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Rizatriptan-AU | List of Excipients, Special Warnings and Precautions for Use |
Revised | Rocaltrol | Nature and Contents of Container, Sponsor |
Revised | Rydapt | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Scheriproct | Dose and Method of Administration |
Revised | Semglee | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Simvastatin Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Sinemet | Dose and Method of Administration |
Revised | Sodium Valproate Juno | TGA Date |
Revised | Sodium Valproate Sandoz | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Somac Injection | Adverse Effects (Undesirable Effects) |
Revised | Somac Tablets and Granules | Adverse Effects (Undesirable Effects) |
Revised | Sublocade | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Suboxone Film | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Subutex | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Symtuza | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Tagrisso | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Tamiflu | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Tamiflu | TGA Date |
Revised | Tamosin | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Temozolomide Juno | Nature and Contents of Container |
Revised | Teriflunomide Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Teveten | Dose and Method of Administration |
Revised | Thyrogen | Adverse Effects (Undesirable Effects) |
Revised | Tramadol AN Injection | Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Trexject | Nature and Contents of Container |
Revised | Tysabri | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Ungvita | Description, Precautions, Therapeutic Indications |
Revised | Valproate Winthrop | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Verzenio | Pharmacological Properties |
Revised | Vimpat | Adverse Effects (Undesirable Effects) |
Revised | Vimpat Injection | Adverse Effects (Undesirable Effects) |
Revised | Zactin | Qualitative and Quantitative Composition |
Revised | Zactin Tabs | Qualitative and Quantitative Composition |
Revised | Zarzio | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ziagel | TGA Date |
Revised | Zircol | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Zostavax | Boxed Warnings, Contraindications |
Revised | Zoton FasTabs | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Zotren | Fertility, Pregnancy and Lactation, Overdose |
Revised | Zumenon | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Deleted | APO-Dipyridamole/Aspirin | |
Deleted | Cyprocur 100 | |
Deleted | Cyprocur 50 | |
Deleted | DBL Doxorubicin Hydrochloride | |
Deleted | DBL Epirubicin Hydrochloride Injection | |
Deleted | DBL Vinorelbine Injection Concentrate | |
Deleted | Dexmedetomidine-Teva | |
Deleted | Difflam-C Anti-inflammatory Antiseptic Solution | |
Deleted | Epirube | |
Deleted | Fluzone High-Dose | |
Deleted | Indapamide Sandoz | |
Deleted | Loette (Old Formulation) | |
Deleted | Meloxibindo | |
Deleted | M-M-R VaxPro | |
Deleted | Novacodone | |
Deleted | Orion Temozolomide | |
Deleted | Paclitaxin | |
Deleted | Tevatrexed | |
Deleted | VivaLAX |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au